News

Genomic Analysis of Uveal Melanoma Case with Good Response to Therapy

Personalized OncoGenomics case report provides insight into uveal melanoma and immune checkpoint inhibitor therapy.

Learn more about Genomic Analysis of Uveal Melanoma Case with Good Response to Therapy

Whole Genome and Transcriptome Analysis Benefits Clinical Cancer Care

A prospective study of 570 Personalized OncoGenomic (POG) patients demonstrates how whole genome and transcriptome analysis can impact cancer treatment.

Learn more about Whole Genome and Transcriptome Analysis Benefits Clinical Cancer Care

Genomic Analysis of Adrenocortical Cancer Identifies Treatment Targets

Results of whole-genome and transcriptome analysis identifies two genomic targets for potential treatment of adrenocortical cancer, a rare disease with limited therapeutic options.

Learn more about Genomic Analysis of Adrenocortical Cancer Identifies Treatment Targets

Evaluating whole genome transcriptome analysis for cancer biomarker discovery and diagnosis

BC Cancer researchers assess whole genome transcriptome analysis for its ability to identify genomic biomarkers and predict the tumour site or tissue of origin for various cancers.

Learn more about Evaluating whole genome transcriptome analysis for cancer biomarker discovery and diagnosis

New animation makes cancer genomics understandable for everyone

A new animated video that explains cancer genomics in simple language and relatable graphics is useful for many audiences including patients that may want to participate in the program, researchers and practitioners working in the field and those helping to educate others on the topic.

Learn more about New animation makes cancer genomics understandable for everyone

Treatment of pediatric chordoma with an immune checkpoint inhibitor slows tumour growth

A POG case report suggests there’s a molecular subset of immunologically hot, INI1-deficient pediatric chordomas and rhabdoid tumours with implications for immune checkpoint inhibitor therapy.

Learn more about Treatment of pediatric chordoma with an immune checkpoint inhibitor slows tumour growth

Pediatric case study demonstrates value in whole genome sequencing for cancer treatment planning

Whole genome sequencing allows for the identification of novel genomic alterations that are not detected by standard clinical techniques. In some cases, identification of these features can reveal therapeutic options for patients with otherwise untreatable cancers.

Learn more about Pediatric case study demonstrates value in whole genome sequencing for cancer treatment planning

Molecular subtypes of common pancreatic cancers can be predicted from tumour characteristics

Gene expression analysis of pancreatic ductal adenocarcinoma (PDAC) tumours enables clinicians to stratify patients into molecular subgroups and select treatments that are best suited to each type; however, molecular subtyping remains cost-prohibitive and is not yet part of routine cancer care.

Learn more about Molecular subtypes of common pancreatic cancers can be predicted from tumour characteristics

A machine learning algorithm for automated tumour sample processing

As researchers work towards establishing whole genome and transcriptome analysis into clinical practice for cancer care, scientists at the GSC continue developing innovative laboratory methods to improve efficiency and accuracy.

Learn more about A machine learning algorithm for automated tumour sample processing

Upcoming Events

GSC Collaborator Forum 2025